z-logo
open-access-imgOpen Access
Current management of hepatocellular carcinoma
Author(s) -
Parissa Tabrizian
Publication year - 2014
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v20.i30.10223
Subject(s) - hepatocellular carcinoma , medicine , cirrhosis , liver transplantation , liver cancer , milan criteria , clinical practice , cancer , intensive care medicine , oncology , hepatocellular cancer , transplantation , physical therapy
Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and leading cause of death among patients with cirrhosis. Treatment guidelines are based according to the Barcelona Clinic Liver Cancer staging system. The choice among therapeutic options that include liver resection, liver transplantation, locoregional, and systemic treatments must be individualized for each patient. The aim of this paper is to review the outcomes that can be achieved in the treatment of HCC with the heterogeneous therapeutic options currently available in clinical practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here